AstraZeneca Pays $68.5 Million to States Settling Off-Label Claims
AstraZeneca (AZ) agreed March 10 to pay 37 states and the District of Columbia a total of $68.5 million to settle allegations the company promoted off-label uses of its antipsychotic drug Seroquel and engaged in other deceptive marketing practices.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.